# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-050688
Filing Date
2022-04-27
Accepted
2022-04-27 08:02:51
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm223678d2_defa14a.htm | DEFA14A | 15521
2 | GRAPHIC | tm223678d2_defa14aimg001.jpg | GRAPHIC | 1561764
3 | GRAPHIC | tm223678d2_defa14aimg002.jpg | GRAPHIC | 112579
| Complete submission text file | 0001104659-22-050688.txt |  | 2320875

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 22856419
SIC: 2834 Pharmaceutical Preparations